Suraksha Diagnostic Limited — Important, 07-04-2025: General Updates

Suraksha Diagnostic Limited has confirmed the successful completion of all definitive agreements for a strategic investment of up to ₹5.19 crore in Fetomat Wellness Private Limited, which will enable Suraksha to acquire a 63% stake, making Fetomat a subsidiary. This acquisition aligns with Suraksha's strategy to enhance its service portfolio by integrating fetal medicine expertise, which could strengthen its market position. Fetomat operates in the healthcare sector, specializing in pregnancy care and maternal medicine, and has shown growth, with a turnover of approximately ₹4.11 crore and an EBITDA of ₹0.56 crore for the last financial year. The expected positive synergies from the acquisition may contribute to further innovation and growth in Suraksha's operations. Investors should watch closely for developments regarding the transaction’s completion and its impact on Suraksha's market presence.